(Total Views: 554)
Posted On: 05/25/2021 6:58:03 AM
Post# of 155757
Ganesha, I have been a shareholder since 2015, read the Message Board regularly, and posted in the past.
IMO, Cytodyn is at a crossroads and I am looking forward to a healthy discussion and/or debate of the merits of different viewpoints as to the path(s) to LL approval here and abroad. I respect all reasonable opinions and sincerely hope disagreements among us do not deteriorate into a negative spiral of name calling and personal attacks on the motives and character of each other.
I appreciate how difficult it has been for Dr. P. and his team to keep LL going and get it to where we are. That said, I have posted in the past that I believe change is required in Cytodyn's leadership to secure regulatory approval and nothing has transpired to change my mind about that However, I have an open mind about how the current management and future leadership could work together to advance LL to approval for the benefit of patients and those who have invested in the company.
IMO, Cytodyn is at a crossroads and I am looking forward to a healthy discussion and/or debate of the merits of different viewpoints as to the path(s) to LL approval here and abroad. I respect all reasonable opinions and sincerely hope disagreements among us do not deteriorate into a negative spiral of name calling and personal attacks on the motives and character of each other.
I appreciate how difficult it has been for Dr. P. and his team to keep LL going and get it to where we are. That said, I have posted in the past that I believe change is required in Cytodyn's leadership to secure regulatory approval and nothing has transpired to change my mind about that However, I have an open mind about how the current management and future leadership could work together to advance LL to approval for the benefit of patients and those who have invested in the company.
(6)
(0)
